| Recruiting | Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220 | Beijing Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) NCT06852820 | Melissa Lumish | Phase 2 |
| Recruiting | Streamlining Radioembolization for CCC and Metastatic Liver Cancer NCT07043387 | Seoul National University Hospital | — |
| Recruiting | A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332 | EtiraRx Australia Pty Ltd | Phase 1 |
| Terminated | Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Pr NCT05582018 | Techsomed Medical Technologies LTD | N/A |
| Unknown | Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decis NCT05986383 | Beijing Tsinghua Chang Gung Hospital | — |
| Withdrawn | Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Pr NCT05641922 | Techsomed Medical Technologies LTD | N/A |
| Recruiting | PDO/PDO-TIL/PDOTS for Drug Screen NCT05913141 | Shanghai Zhongshan Hospital | — |
| Unknown | Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard T NCT05643417 | Fudan University | Phase 1 |
| Recruiting | Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases NCT05240950 | Changhai Hospital | Phase 1 |
| Recruiting | ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357 | Eureka Therapeutics Inc. | Phase 1 / Phase 2 |
| Unknown | Liver Transplantation for Unresectable GIST Liver Metastases NCT04825470 | Hospital Universitario Virgen de la Arrixaca | N/A |
| Recruiting | T-Cell Therapy (ECT204) in Adults With Advanced HCC NCT04864054 | Eureka Therapeutics Inc. | Phase 1 / Phase 2 |
| Completed | Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Proce NCT04970212 | Techsomed Medical Technologies LTD | — |
| Recruiting | Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases NCT04616495 | Hospital Universitario La Fe | — |
| Terminated | Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) NCT04502082 | Eureka Therapeutics Inc. | Phase 1 |
| Unknown | DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criter NCT04708483 | Hyperfusion | N/A |
| Unknown | ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer NCT03965546 | First Affiliated Hospital Xi'an Jiaotong University | EARLY_Phase 1 |
| Terminated | Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma NCT03998033 | Eureka Therapeutics Inc. | Phase 1 |
| Completed | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma NCT03888859 | First Affiliated Hospital Xi'an Jiaotong University | EARLY_Phase 1 |
| Terminated | Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma NCT03349255 | Aeon Therapeutics (Shanghai) Co., Ltd. | Phase 1 |
| Withdrawn | Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium NCT03215355 | Slawa Cwajna | Phase 4 |
| Withdrawn | Treat Primary and Metastatic Liver Tumors NCT05240040 | Methodist Health System | — |
| Terminated | Prospective Tumor Response Evaluation NCT02787954 | The University of Texas Health Science Center, Houston | — |
| Completed | Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body NCT02201797 | Asan Medical Center | N/A |
| Unknown | Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After T NCT01895010 | Fudan University | Phase 2 |
| Unknown | Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma NCT01442324 | Azienda Ospedaliera di Padova | N/A |
| Completed | Chemotherapy for Resectable Colorectal Liver Metastases NCT04513457 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | — |
| Withdrawn | Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary L NCT00510627 | Boston Scientific Corporation | Phase 4 |
| Completed | Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer NCT00604409 | Fox Chase Cancer Center | Phase 1 |
| No Longer Available | Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets NCT01728051 | Delcath Systems Inc. | — |